Publications
Detailed Information
Focal amplification and oncogene dependency of GAB2 in breast cancer
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Bocanegra, M. | - |
dc.contributor.author | Bergamaschi, A. | - |
dc.contributor.author | Kim, Y. H. | - |
dc.contributor.author | Miller, M. A. | - |
dc.contributor.author | Kao, J. | - |
dc.contributor.author | Han, W. | - |
dc.contributor.author | Jeffrey, S. S. | - |
dc.contributor.author | Borresen-Dale, A-L | - |
dc.contributor.author | Pollack, J. R. | - |
dc.contributor.author | Huntsman, D. G. | - |
dc.contributor.author | Noh, D-Y | - |
dc.contributor.author | Langerod, A. | - |
dc.contributor.author | Rajput, A. B. | - |
dc.date.accessioned | 2012-06-29T05:52:14Z | - |
dc.date.available | 2012-06-29T05:52:14Z | - |
dc.date.issued | 2010-02-04 | - |
dc.identifier.citation | ONCOGENE; Vol.29 5; 774-779 | ko_KR |
dc.identifier.issn | 0950-9232 | - |
dc.identifier.uri | https://hdl.handle.net/10371/77950 | - |
dc.description.abstract | DNA amplifications in breast cancer are frequent on chromosome 11q, in which multiple driver oncogenes likely reside in addition to cyclin D1 (CCND1). One such candidate, the scaffolding adapter protein, GRB2-associated binding protein 2 (GAB2), functions in ErbB signaling and was recently shown to enhance mammary epithelial cell proliferation, and metastasis of ERBB2 (HER2/neu)-driven murine breast cancer. However, the amplification status and function of GAB2 in the context of amplification remain undefined. In this study, by genomic profiling of 172 breast tumors, and fluorescence in situ hybridization validation in an independent set of 210 scorable cases, we observed focal amplification spanning GAB2 (11q14.1) independent of CCND1 (11q13.2) amplification, consistent with a driver role. Further, small interfering RNA (siRNA)-mediated knockdown of GAB2 in breast cancer lines (SUM52, SUM44PE and MDA468) with GAB2 amplification revealed a dependency on GAB2 for cell proliferation, cell-cycle progression, survival and invasion, likely mediated through altered phosphatidylinositol 3-kinase (PI3K) and mitogen-activated protein kinase (MAPK) signaling. GAB2 knockdown also reduced proliferation and survival in a cell line (BT474) with ERBB2 amplification, consistent with the possibility that GAB2 can function downstream of ERBB2. Our studies implicate focal amplification of GAB2 in breast carcinogenesis, and underscore an oncogenic role of scaffolding adapter proteins, and a potential new point of therapeutic intervention. Oncogene (2010) 29, 774-779; doi: 10.1038/onc.2009.364; published online 2 November 2009 | ko_KR |
dc.language.iso | en | ko_KR |
dc.publisher | NATURE PUBLISHING GROUP | ko_KR |
dc.subject | GAB2 | ko_KR |
dc.subject | genomic profiling | ko_KR |
dc.subject | breast cancer | ko_KR |
dc.subject | oncogene dependency | ko_KR |
dc.subject | array-based comparative genomic hybridization | ko_KR |
dc.subject | DNA amplification | ko_KR |
dc.title | Focal amplification and oncogene dependency of GAB2 in breast cancer | ko_KR |
dc.type | Article | ko_KR |
dc.identifier.doi | 10.1038/onc.2009.364 | - |
dc.citation.journaltitle | ONCOGENE | - |
dc.description.citedreference | Kao J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006146 | - |
dc.description.citedreference | Bergamaschi A, 2008, MOL ONCOL, V2, P327, DOI 10.1016/j.molonc.2008.09.004 | - |
dc.description.citedreference | Tibshirani R, 2008, BIOSTATISTICS, V9, P18, DOI 10.1093/biostatistics/kxm013 | - |
dc.description.citedreference | Ke Y, 2007, ONCOGENE, V26, P4951, DOI 10.1038/sj.onc.1210315 | - |
dc.description.citedreference | Jemal A, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1672 | - |
dc.description.citedreference | Chin K, 2006, CANCER CELL, V10, P529, DOI 10.1016/j.ccr.2006.10.009 | - |
dc.description.citedreference | Sarmay G, 2006, IMMUNOL LETT, V104, P76, DOI 10.1016/j.imlet.2005.11.017 | - |
dc.description.citedreference | Brummer T, 2006, J BIOL CHEM, V281, P626 | - |
dc.description.citedreference | Bentires-Alj M, 2006, NAT MED, V12, P114, DOI 10.1038/nm1341 | - |
dc.description.citedreference | Hughes-Davies L, 2003, CELL, V115, P523 | - |
dc.description.citedreference | Ischenko I, 2003, ONCOGENE, V22, P6311, DOI 10.1038/sj.onc.1206742 | - |
dc.description.citedreference | Ormandy CJ, 2003, BREAST CANCER RES TR, V78, P323 | - |
dc.description.citedreference | Gu HH, 2003, TRENDS CELL BIOL, V13, P122, DOI 10.1016/S0962-8924(03)00002-3 | - |
dc.description.citedreference | Pollack JR, 2002, P NATL ACAD SCI USA, V99, P12963, DOI 10.1073/pnas.162471999 | - |
dc.description.citedreference | Daly RJ, 2002, ONCOGENE, V21, P5175, DOI 10.1038/sj.onc.1205522 | - |
dc.description.citedreference | Sattler M, 2002, CANCER CELL, V1, P479 | - |
dc.description.citedreference | Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869 | - |
dc.description.citedreference | PEGRAM MD, 2000, CANC TREAT RES, V103, P57 | - |
dc.description.citedreference | KARLSEDER J, 1994, GENE CHROMOSOME CANC, V9, P42 | - |
dc.description.tc | 7 | - |
- Appears in Collections:
- Files in This Item:
- There are no files associated with this item.
Item View & Download Count
Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.